Senior Research Associate
Sail Biomedicines
Senior Research Associate
Sail Biomedicines
In vivo programmable RNA CAR-T therapies
About Sail:
Sail Biomedicines is pioneering the integrative design and deployment of fully programmable medicines to transform patient care. Sail’s platform combines first-in-class programmable circular RNA technology (Endless RNA™ or eRNA), and an industry-leading platform of programmable nanoparticles, utilizing natural components, to unlock comprehensive programming of medicines for the first time. By leveraging cutting-edge eRNA and nanoparticle deployment technology, Sail is also making unparalleled use of AI techniques to identify and design fully programmable medicines that are potent, targeted, versatile, and tunable. Sail was founded by Flagship Pioneering.
The Role:
Sail Biomedicines is seeking a motivated Senior Research Associate to join our Targeted Drug Delivery team. This role will support the development of targeted lipid nanoparticle (TNP) formulations and is a unique opportunity to be an integral part of a team dedicated to creating a transformative delivery platform for precision-targeted therapeutics.
This lab-based, onsite position requires hands-on experimental work, collaborative problem-solving, and close collaboration with cross-functional teams to drive project success. The ideal candidate will have experience in nanoparticle formulation, ligand conjugation, analytical characterization, and robust record-keeping. You will work closely with scientists and cross-functional collaborators to execute experiments, generate high-quality data, and contribute to advancing Sail’s delivery platform.
Responsibilities:
LNP Formulation & Evaluation
Data Analysis & Collaboration
Required Qualifications:
Preferred Qualifications:
Salary Range: $70,000 - $105,000
Sail Biomedicines is an Equal Opportunity Employer. Sail does not discriminate based on race, religion, color, sex, gender identity, sexual orientation, age, national origin, veteran status, or any other status protected under federal, state, or local law.
In vivo programmable RNA CAR-T therapies
Sail Biomedicines creates programmable RNA medicines that enable in vivo CAR-T therapies for autoimmune diseases, turning the patient’s body into the site of T-cell engineering. Its platform combines Endless RNA circular RNA, a library of targeted nanoparticles for cell-specific delivery, and AI-powered design tools to program T cells inside the body. It differentiates from competitors by delivering and programming CAR-T cells in vivo rather than via ex vivo cell manufacturing, leveraging circular RNA and targeted nanoparticles, with support from its Flagship Pioneering lineage and a Johnson & Johnson collaboration. The goal is to provide scalable, durable immune resets and remission for immune-mediated diseases with broader, more accessible treatments.
Explore more opportunities at Sail Biomedicines